Page 244 - SAHCS HIVMed Journal Vol 20 No 1 2019
P. 244

Page 7 of 7  Original Research


              Health for providing access to the data used in this analysis.   10. Meintjes G, Black J, Conradie F, et al. Adult antiretroviral therapy guidelines 2014.
                                                                      South  Afr  J  HIV  Med.  2014;15(4):121–143.  https://doi.org/10.4102/hivmed.
              This study was supported by the Research and Publications   v15i4.330
              Committee of the University of Venda, South Africa, and the   11. Corbeau P, Reynes J. Immune reconstitution under antiretroviral therapy: the new
              South  African Medical Research Council (RCDI) through   challenge  in  HIV-1  infection.  Blood.  2011;117(21):5582–5590.  https://doi.org/
                                                                      10.1182/blood-2010-12-322453
              funding received from the South African National Treasury.   12. Zoufaly  A,  An  Der  Heiden  M,  Kollan  C,  et  al.  Clinical  outcome  of  HIV  infected
                                                                      patients with discordant virological and immunological response to antiretroviral
                                                                      therapy. J Infect Dis. 2011;203(3):364–371. https://doi.org/10.1093/jinfdis/jiq055
              Competing interests                                   13. Billioux A, Nakigozi G, Newell K, et al. Durable suppression of HIV-1 after virologic
                                                                      monitoring-based  antiretroviral  adherence  counselling  in  Rakai,  Uganda.  PLoS
              The authors declare that they have no financial or personal   One [serial online]. 2015 [cited 2016 Mar 27];10(5). Available from: https://doi.
                                                                      org/10.1371/journal.pone.0127235
              relationship(s) that may have inappropriately influenced   14. Davey  DJ,  Abrahams  Z,  Feinberg  M,  et  al.  Factors  associated  with  recent
              them in writing this article.                           unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral
                                                                      therapy  in  South  Africa.  Int  J  STD  AIDS.  2018;29(6):603–610.  https://doi.org/
                                                                      10.1177/ 0956462417748859
              Authors’ contributions                                15. Jobanputra K, Parker LA, Azih C, et al. Factors associated with virological failure
                                                                      and suppression after enhanced adherence counselling, in children, adolescents
                                                                      and adults on antiretroviral therapy for HIV in Swaziland. PLoS One. 2015;10(2):
              A.E. was the project leader and also contributed to the study   e0116144. https://doi.org/10.1371/journal.pone.0116144
              design and analysis. P.O.B. and H.A. were responsible for the   16. Bello  KJ,  Mesner  O,  O’Bryan  TA,  et  al.  Factors  associated  with  10  years  of
                                                                      continuous viral load suppression on HAART. BMC Infect Dis [serial online]. 2016
              conceptual contributions to the study design.           [cited  2016  Dec  20];16(351).  Available  from:  https://doi.org/10.1186/s12879-
                                                                      016-1677-x
                                                                    17. South  African  National  Department  of  Health.  National  antiretroviral  therapy
              References                                              guidelines. Pretoria: Jacana; 2004.
                                                                    18. South African National Department of Health. South African standard treatment
               1.  Statistics South Africa. Mortality and causes of death in South Africa, 2013: Findings   guidelines  and  essential  medicines  list  –  Hospital  level  for  Adults.  Pretoria:
                                                                      South African National Department of Health; 2010.
                from  death  notification  [homepage  on  the  Internet].  2015  [cited  2016  Apr  26].
                Available from: http://www.statssa.gov.za/publications/P03093/P030932013.pdf   19. Muzah BP, Takuva S, Maskew M, Delaney-Moretlwe S. Risk factors for discordant
               2. Whiteside A, Cohen J, Strauss M. Reconciling the science and policy divide: The   immune response among HIV-infected patients initiating antiretroviral therapy:
                reality of scaling up antiretroviral therapy in South Africa. South Afr J HIV Med.   A retrospective cohort study. South Afr J HIV Med. 2012;13(4):168–172. https://
                                                                      doi.org/https://doi.org/10.4102/sajhivmed.v13i4.110
                2015;16(1):355. https://doi.org/10.4102/sajhivmed.v16i1.355
               3.  UNAIDS.  Prevention  gap  report  [homepage  on  the  Internet].  2016  [cited  2016   20. Liddy C, Wiens M, Hogg W. Methods to achieve high interrater reliability in data
                                                                      collection from primary care medical records. Ann Fam Med. 2011;9(1):57–62.
                Apr  05].  Available  from:  http://www.unaids.org/sites/default/files/media_asset/   https://doi.org/10.1370/afm.1195
                2016-prevention-gap-report_en.pdf
               4. Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA   21. Cameron D, Gerber A, Mbatha M, Mutyabule J, Swart H. Nurse Initiation and
                                                                      maintenance of patients on antiretroviral therapy: Are nurses in primary care clinics
                concentrations and incidence of HIV-1 among injecting drug users: prospective   initiating  ART  after  attending  NIMART  training?  S  Afr  Med  J.  2012;102: 98–100.
                cohort study. BMJ. 2009;338(1649). https://doi.org/10.1136/bmj.b1649  https://doi.org/10.7196/SAMJ.5195
               5. Montaner JSG, Lima VD, Barrios R, et al. Association of highly active antiretroviral   22. Johnson LF. Access to antiretroviral treatment in South Africa, 2004–2011. South
                therapy coverage, population viral load, and yearly new HIV diagnoses in British   Afr  J  HIV  Med  [serial  online].  2012  [cited  2016  Apr  19];13(1).  Available  from:
                Columbia, Canada: A population-based study. Lancet. 2010;376 (9740):532–539.   http://sajhivmed.org.za/index.php/hivmed/article/view/156/261
                https://doi.org/10.1016/S0140-6736(10)60936-1
               6. Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of   23. Gichangi A, Wambua J, Gohole A, et al. Provision of oral HIV self-kits triples uptake
                                                                      of  HIV  testing  among  male  partners  of  antenatal  care  clients:  results  of  a
                HIV transmission in serodifferent couples when the HIV-positive partner is using   randomised trial. Poster session presented at: 21st International AIDS conference
                suppressive antiretroviral therapy. JAMA. 2016;316(2):171–181. https://doi.org/   of the International AIDS Society; 2016 Jul 18–22; Durban.
                10.1001/jama.2016.5148                              24. Boender TS, Sigaloff KCE, McMahon JH, et al. Long-term virological outcomes of
               7. McMahon JH, Elliot JH, Bertagnolio S, Kubiak R, Jordan, JR. Viral Suppression after   first-line  antiretroviral  therapy  for  HIV-1  in  low-  and  middle-income  countries:
                12  months  of  antiretroviral  therapy  in  low-and-medium-income  countries:  a   A  systematic  review  and  meta-analysis.  Clin  Infect  Dis.  2015;61(9):1453–1461.
                systematic  review.  Bull  World  Health  Org.  2013;91:377–385.  https://doi.org/   https://doi.org/10.1093/cid/civ556
                10.2471/BLT.12.112946                               25. Mlangeni  N,  Senkubuge  F.  Antiretroviral  therapy  programme  outcomes  in
               8. South African National Department of Health. South African standard treatment   Tshwane  district,  South  Africa:  A  5-year  retrospective  study.  S  Afr  Med  J.
                guidelines  and  essential  medicines  list  –  Hospital  level  for  Adults.  Pretoria:   2016;106(4): 365–368. https://doi.org/10.7196/SAMJ.2016.v106i4.9375
                South African National Department of Health; 2012.  26. Boily M, Baggaley RF, Wang L, et al. Heterosexual risk of HIV-1 infection per sexual
               9. Bartlett JG, Gallant JE, Pham PA. Medical Management of HIV infection. 16th ed.   act: systemic review and meta-analysis of observational studies. Lancet Infect Dis.
                Durham, NC: Knowledge Source Solutions; 2012.         2009;9:118–129. https://doi.org/10.1016/S1473-3099(09)70021-0


























                                           http://www.sajhivmed.org.za 237  Open Access
   239   240   241   242   243   244   245   246   247   248   249